The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma
JH Saunders, S Al-Zubaidi, RC Waller… - Diseases of the …, 2020 - academic.oup.com
Endoscopic resection (ER) for early (pT1) esophageal adenocarcinoma can be justified if
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma
JH Saunders, S Al-Zubaidi… - Diseases of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Endoscopic resection (ER) for early (pT1) esophageal adenocarcinoma can be justified if
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
JH Saunders, S Al-Zubaidi, RC Waller… - Diseases of the …, 2020 - search.ebscohost.com
Endoscopic resection (ER) for early (pT1) esophageal adenocarcinoma can be justified if
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
JH Saunders, S Al-Zubaidi, RC Waller… - Diseases of the …, 2020 - europepmc.org
Endoscopic resection (ER) for early (pT1) esophageal adenocarcinoma can be justified if
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma
JH Saunders, S Al-Zubaidi, RC Waller… - Diseases of the …, 2020 - academic.oup.com
Endoscopic resection (ER) for early (pT1) esophageal adenocarcinoma can be justified if
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …